AAAAAA

   
Results: 1-25 | 26-46 |
Results: 26-46/46

Authors: ESTEY EH
Citation: Eh. Estey, TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA AND MYELODYSPLASTIC SYNDROME, Seminars in hematology, 32(2), 1995, pp. 132-151

Authors: ESTEY EH KEATING MJ
Citation: Eh. Estey et Mj. Keating, POSTREMISSION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA, The New England journal of medicine, 332(5), 1995, pp. 334-334

Authors: ESTROV Z BLACK RA SLEATH PR HARRIS D VAN Q LAPUSHIN R ESTEY EH TALPAZ M
Citation: Z. Estrov et al., EFFECT OF INTERLEUKIN-1-BETA CONVERTING-ENZYME-INHIBITOR ON ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION, Blood, 86(12), 1995, pp. 4594-4602

Authors: MARLTON P CLAXTON DF LIU P ESTEY EH BERAN M LEBEAU M TESTA JR COLLINS FS ROWLEY JD SICILIANO MJ
Citation: P. Marlton et al., MOLECULAR CHARACTERIZATION OF 16P DELETIONS ASSOCIATED WITH INVERSION-16 DEFINES THE CRITICAL FUSION FOR LEUKEMOGENESIS, Blood, 85(3), 1995, pp. 772-779

Authors: ZHAO L CHANG KS ESTEY EH HAYES K DEISSEROTH AB LIANG JC
Citation: L. Zhao et al., DETECTION OF RESIDUAL LEUKEMIC-CELLS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA BY THE FLUORESCENCE IN-SITU HYBRIDIZATION METHOD - POTENTIAL FOR PREDICTING RELAPSE, Blood, 85(2), 1995, pp. 495-499

Authors: GHADDAR HM PLUNKETT W KANTARJIAN HM PIERCE S FREIREICH EJ KEATING MJ ESTEY EH
Citation: Hm. Ghaddar et al., LONG-TERM RESULTS FOLLOWING TREATMENT OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA WITH CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE, Leukemia, 8(8), 1994, pp. 1269-1274

Authors: SEYMOUR JF PIERCE SA KANTARJIAN HM KEATING MJ ESTEY EH
Citation: Jf. Seymour et al., INVESTIGATION OF KARYOTYPIC, MORPHOLOGIC AND CLINICAL-FEATURES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA BLAST CELLS EXPRESSING THE NEURAL CELL-ADHESION MOLECULE (CD56), Leukemia, 8(5), 1994, pp. 823-826

Authors: GHADDAR HM STASS SA PIERCE S ESTEY EH
Citation: Hm. Ghaddar et al., CYTOGENETIC EVOLUTION FOLLOWING THE TRANSFORMATION OF MYELODYSPLASTIC-SYNDROME TO ACUTE MYELOGENOUS LEUKEMIA - IMPLICATIONS ON THE OVERLAP BETWEEN THE 2 DISEASES, Leukemia, 8(10), 1994, pp. 1649-1653

Authors: MARUYAMA F STASS SA ESTEY EH CORK A HIRANO M INO T FREIREICH EJ YANG PR CHANG KS
Citation: F. Maruyama et al., DETECTION OF AML1 ETO FUSION TRANSCRIPT AS A TOOL OF DIAGNOSING T(821) POSITIVE ACUTE MYELOGENOUS LEUKEMIA/, Leukemia, 8(1), 1994, pp. 40-45

Authors: ESTEY EH
Citation: Eh. Estey, REGROWTH RESISTANCE, Leukemia research, 18(3), 1994, pp. 161-161

Authors: KANTARJIAN HM OBRIEN S SMITH T ESTEY EH BERAN M PRETI A PIERCE S KEATING MJ
Citation: Hm. Kantarjian et al., ACUTE LYMPHOCYTIC-LEUKEMIA IN THE ELDERLY - CHARACTERISTICS AND OUTCOME WITH THE VINCRISTINE-ADRIAMYCIN-DEXAMETHASONE (VAD) REGIMEN, British Journal of Haematology, 88(1), 1994, pp. 94-100

Authors: ESTROV Z BLACK RA KURZROCK R WETZLER M SLEATH PR ESTEY EH HARRIS D VAN Q TALPAZ M
Citation: Z. Estrov et al., IL-1-BETA CONVERTING-ENZYME (ICE) INHIBITOR SUPPRESSES AML BLAST PROLIFERATION, Blood, 84(10), 1994, pp. 10000380-10000380

Authors: ESTEY EH
Citation: Eh. Estey, USE OF COLONY-STIMULATING FACTORS IN THE TREATMENT OF ACUTE MYELOID-LEUKEMIA, Blood, 83(8), 1994, pp. 2015-2019

Authors: SEYMOUR JF KURZROCK R FREIREICH EJ ESTEY EH
Citation: Jf. Seymour et al., 2-CHLORODEOXYADENOSINE INDUCES DURABLE REMISSIONS AND PROLONGED SUPPRESSION OF CD4(-CELL LEUKEMIA() LYMPHOCYTE COUNTS IN PATIENTS WITH HAIRY), Blood, 83(10), 1994, pp. 2906-2911

Authors: THALL PF ESTEY EH
Citation: Pf. Thall et Eh. Estey, A BAYESIAN STRATEGY FOR SCREENING CANCER TREATMENTS PRIOR TO PHASE-IICLINICAL-EVALUATION, Statistics in medicine, 12(13), 1993, pp. 1197-1211

Authors: ESTEY EH KANTARJIAN H KEATING M
Citation: Eh. Estey et al., IDARUBICIN PLUS CONTINUOUS-INFUSION HIGH-DOSE CYTARABINE AS TREATMENTFOR PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME, Seminars in oncology, 20(6), 1993, pp. 1-5

Authors: JAIYESIMI IA KANTARJIAN HM ESTEY EH
Citation: Ia. Jaiyesimi et al., ADVANCES IN THERAPY FOR HAIRY-CELL LEUKEMIA - A REVIEW, Cancer, 72(1), 1993, pp. 5-16

Authors: SEYMOUR JF ESTEY EH
Citation: Jf. Seymour et Eh. Estey, THE PROGNOSTIC-SIGNIFICANCE OF AUER RODS IN MYELODYSPLASIA, British Journal of Haematology, 85(1), 1993, pp. 67-76

Authors: SEYMOUR JF PIERCE SA KANTARJIAN H KEATING MJ ESTEY EH
Citation: Jf. Seymour et al., NEURAL CELL-ADHESION MOLECULE (CD56) EXPRESSION IS ASSOCIATED WITH FAB SUBTYPE, CYTOGENETICS AND SKIN INFILTRATION IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 82(10), 1993, pp. 10000126-10000126

Authors: SEYMOUR JF KURZROCK R FREIREICH EJ ESTEY EH
Citation: Jf. Seymour et al., PROLONGED CD4-CHLORODEOXYADENOSINE (2-CDA) IN PATIENTS (PTS) WITH HAIRY-CELL LEUKEMIA (HCL)( LYMPHOCYTOPENIA IS THE COST OF DURABLE RESPONSES TO 2), Blood, 82(10), 1993, pp. 10000142-10000142

Authors: READING CL ESTEY EH HUH YO CLAXTON DF SANCHEZ G TERSTAPPEN LWMM OBRIEN MC BARON S DEISSEROTH AB
Citation: Cl. Reading et al., EXPRESSION OF UNUSUAL IMMUNOPHENOTYPE COMBINATIONS IN ACUTE MYELOGENOUS LEUKEMIA, Blood, 81(11), 1993, pp. 3083-3090
Risultati: 1-25 | 26-46 |